NMD Pharma

Financing roundup: Electra’s Star debut, Kallyope’s cash, Memo’s money & more
MedCity News
Tue, 02/22/22 - 10:48 am
biotech
IPOs
Electra Therapeutics
Kallyope
Memo Therapeutics
Centauri Therapeutics
SpliceBio
Third Harmonic Bio
Synthego
NMD Pharma
funding
Roche-backed biotech refuels with $40M to steer neuromuscular candidate toward late-stage trials
Endpoints
Tue, 02/15/22 - 10:27 am
NMD Pharma
Roche
neuromuscular disease
funding